Who Supplies Tamoxifen? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Tamoxifen exports, with 220+ registered manufacturers shipping to buyers across 104+ countries — yet a handful of companies dominate the shipments. EUGIA PHARMA SPECIALITIES LIMITED holds the largest share at 31.9% (export value: $4.7M). Close behind, PRATAP ORGANICS PRIVATE LIMITED (19.1%, $2.8M). GRANULES INDIA LIMITED (10.6%, $1.6M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Tamoxifen? Top Manufacturers & Their Buyers
Flow of Tamoxifen from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Tamoxifen Supplier Network — Key Market Intelligence
The Tamoxifen export market from India is led by EUGIA PHARMA SPECIALITIES LIMITED, which alone commands a 31.9% share, shipping $4.7M worth of product across 182 shipments. The second-largest exporter, PRATAP ORGANICS PRIVATE LIMITED, contributes $2.8M (19.1%) to the overall market. Combined, the top two suppliers alone account for 51.0% of all Tamoxifen exports, indicating a relatively concentrated supply base.
Across all 220 tracked manufacturers, the total Tamoxifen export value stands at $14.7M from 3.1K shipments. The market average shipment value is $4.7K. The single largest buyer relationship in terms of trade value is AUROBINDO PHARMA USA. INC, receiving $2.4M worth of product.
The combined buyer network spans 11 named purchasing companies, including AUROBINDO PHARMA USA. INC, AUROLOGISTICS LLC AUROBINDO PHARM, ALIUD PHARMA GMBH, TILLOMED LABORATORIES LIMITED, PIPHLPT and 6 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1EUGIA PHARMA SPECIALITIES LIMITED
EUGIA PHARMA SPECIALITIES LIMITED is the first-largest Tamoxifen exporter from India, with a market share of 31.9% and a total export value of $4.7M across 182 shipments. Their average shipment value of $25.8K is above the market average of $4.7K, suggesting premium or bulk contract pricing.
EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. AUROBINDO PHARMA USA. INC is the dominant customer, accounting for 51.9% of this supplier's tracked business. Top customers include:
• AUROBINDO PHARMA USA. INC — $2.4M across 95 shipments (51.9% of this supplier's total exports)
• AUROBINDO PHARMA USA. INC — $1.2M across 46 shipments (25.2% of this supplier's total exports)
• AUROBINDO PHARMA USA. INC — $400.9K across 16 shipments (8.5% of this supplier's total exports)
• AUROBINDO PHARMA USA. INC — $351.2K across 14 shipments (7.5% of this supplier's total exports)
• AUROLOGISTICS LLC AUROBINDO PHARM — $322.2K across 12 shipments (6.9% of this supplier's total exports)
Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $25.8K is 450% above the market average of $4.7K, consistent with large-order contracts or value-added formulations.
2PRATAP ORGANICS PRIVATE LIMITED
PRATAP ORGANICS PRIVATE LIMITED is the second-largest Tamoxifen exporter from India, with a market share of 19.1% and a total export value of $2.8M across 7 shipments. Their average shipment value of $402.6K is above the market average of $4.7K, suggesting premium or bulk contract pricing.
PRATAP ORGANICS PRIVATE LIMITED serves 3 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• To the Order of — $1.2M across 3 shipments (43.0% of this supplier's total exports)
• TO THE ORDER — $1.2M across 3 shipments (41.1% of this supplier's total exports)
• To The Order — $445.9K across 1 shipments (15.8% of this supplier's total exports)
Key Insight: PRATAP ORGANICS PRIVATE LIMITED's per-shipment value of $402.6K is 8482% above the market average of $4.7K, consistent with large-order contracts or value-added formulations.
3GRANULES INDIA LIMITED
GRANULES INDIA LIMITED is the third-largest Tamoxifen exporter from India, with a market share of 10.6% and a total export value of $1.6M across 25 shipments. Their average shipment value of $62.6K is above the market average of $4.7K, suggesting premium or bulk contract pricing.
GRANULES INDIA LIMITED serves 1 named buyer in our database. ALIUD PHARMA GMBH is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• ALIUD PHARMA GMBH — $1.6M across 25 shipments (100.0% of this supplier's total exports)
Key Insight: GRANULES INDIA LIMITED's per-shipment value of $62.6K is 1235% above the market average of $4.7K, consistent with large-order contracts or value-added formulations.
4BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED is the fourth-largest Tamoxifen exporter from India, with a market share of 4.6% and a total export value of $670.5K across 48 shipments. Their average shipment value of $14.0K is above the market average of $4.7K, suggesting premium or bulk contract pricing.
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED serves 5 named buyers in our database. TILLOMED LABORATORIES LIMITED is the dominant customer, accounting for 54.5% of this supplier's tracked business. Top customers include:
• TILLOMED LABORATORIES LIMITED — $365.3K across 26 shipments (54.5% of this supplier's total exports)
• PIPHLPT — $212.7K across 15 shipments (31.7% of this supplier's total exports)
• TILLABLTD — $38.8K across 3 shipments (5.8% of this supplier's total exports)
• PIPHLPT PINYO PHARMA — $27.5K across 2 shipments (4.1% of this supplier's total exports)
• PIPHLPT PINYO PHARMA — $26.3K across 2 shipments (3.9% of this supplier's total exports)
Key Insight: BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED's per-shipment value of $14.0K is 198% above the market average of $4.7K, consistent with large-order contracts or value-added formulations.
5KHANDELWAL LABORATORIES PRIVATE LIMITED
KHANDELWAL LABORATORIES PRIVATE LIMITED is the fifth-largest Tamoxifen exporter from India, with a market share of 3.2% and a total export value of $476.9K across 32 shipments. Their average shipment value of $14.9K is above the market average of $4.7K, suggesting premium or bulk contract pricing.
KHANDELWAL LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER OF TMBT — $118.0K across 8 shipments (24.7% of this supplier's total exports)
• TMBTHANACHART BANKPUBLIC CO LTD — $115.0K across 8 shipments (24.1% of this supplier's total exports)
• TMBTHANACHART BANK — $115.0K across 8 shipments (24.1% of this supplier's total exports)
• TO THE ORDER OF TMBI — $115.0K across 8 shipments (24.1% of this supplier's total exports)
• ADVANCED SYNERGY CO — $14.0K across 1 shipments (2.9% of this supplier's total exports)
Key Insight: KHANDELWAL LABORATORIES PRIVATE LIMITED's per-shipment value of $14.9K is 218% above the market average of $4.7K, consistent with large-order contracts or value-added formulations.
6WOCKHARDT LIMITED
WOCKHARDT LIMITED is the fifth-largest Tamoxifen exporter from India, with a market share of 1.8% and a total export value of $269.1K across 9 shipments. Their average shipment value of $29.9K is above the market average of $4.7K, suggesting premium or bulk contract pricing.
WOCKHARDT LIMITED serves 1 named buyer in our database. WOCKHARDT UK LIMITED is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• WOCKHARDT UK LIMITED — $269.1K across 9 shipments (100.0% of this supplier's total exports)
Key Insight: WOCKHARDT LIMITED's per-shipment value of $29.9K is 537% above the market average of $4.7K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Tamoxifen Flows
Once Tamoxifen leaves the manufacturing plants of companies like EUGIA PHARMA SPECIALITIES LIMITED and PRATAP ORGANICS PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $14.7M. United States absorbs the largest share at 42.5% ($6.3M), followed by Germany (24.0%) and United Kingdom (11.1%).
In United States — the top destination — named importers include AUROBINDO PHARMA USA., INC,, AUROBINDO PHARMA USA INC, AUROLOGISTICS LLC, (AUROBINDO PHARM. In Germany, key buyers are ALIUD PHARMA GMBH.
This geographic spread reflects Tamoxifen's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Tamoxifen Go? Top Importing Countries & Their Buyers
Trade flow of Tamoxifen exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Tamoxifen imports from India, with a total trade value of $6.3M across 155 shipments — representing a 42.5% share of all Tamoxifen exports. The average shipment value of $40.4K is above the global average of $4.7K, indicating high-value procurement contracts or branded formulations. This market is served by 7 tracked buyers.
Named Tamoxifen importers in United States: AUROBINDO PHARMA USA., INC, is the largest buyer, accounting for 40.4% ($2.5M) of this market's total imports.
• AUROBINDO PHARMA USA., INC, — $2.5M (40.4% of United States's total)
• AUROBINDO PHARMA USA INC — $1.2M (18.9% of United States's total)
• AUROLOGISTICS LLC, (AUROBINDO PHARM — $1.2M (18.9% of United States's total)
Key Insight: United States's per-shipment average of $40.4K (761% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Tamoxifen imports from India.
2Germany
Germany ranks as the second-largest destination for Tamoxifen imports from India, with a total trade value of $3.5M across 25 shipments — representing a 24.0% share of all Tamoxifen exports. The average shipment value of $141.2K is above the global average of $4.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Tamoxifen importers in Germany: ALIUD PHARMA GMBH is the largest buyer, accounting for 52.9% ($1.9M) of this market's total imports.
• ALIUD PHARMA GMBH — $1.9M (52.9% of Germany's total)
Key Insight: Germany's per-shipment average of $141.2K (2911% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Germany is a key market for Tamoxifen imports from India.
3United Kingdom
United Kingdom ranks as the third-largest destination for Tamoxifen imports from India, with a total trade value of $1.6M across 41 shipments — representing a 11.1% share of all Tamoxifen exports. The average shipment value of $39.8K is above the global average of $4.7K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Tamoxifen importers in United Kingdom: BELLS HEALTHCARE is the largest buyer, accounting for 25.5% ($416.4K) of this market's total imports.
• BELLS HEALTHCARE — $416.4K (25.5% of United Kingdom's total)
• WOCKHARDT UK LIMITED — $409.8K (25.1% of United Kingdom's total)
• TILLOMED LABORATORIES LIMITED — $404.1K (24.7% of United Kingdom's total)
Key Insight: United Kingdom's per-shipment average of $39.8K (749% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Tamoxifen imports from India.
4Belgium
Belgium ranks as the fourth-largest destination for Tamoxifen imports from India, with a total trade value of $1.2M across 0 shipments — representing a 7.9% share of all Tamoxifen exports. The average shipment value of $1.2M is above the global average of $4.7K, indicating high-value procurement contracts or branded formulations.
Key Insight: Belgium's per-shipment average of $1.2M (24549% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belgium is a key market for Tamoxifen imports from India.
5Thailand
Thailand ranks as the fifth-largest destination for Tamoxifen imports from India, with a total trade value of $1.0M across 18 shipments — representing a 6.9% share of all Tamoxifen exports. The average shipment value of $56.6K is above the global average of $4.7K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Tamoxifen importers in Thailand: PIPHLPT is the largest buyer, accounting for 20.9% ($212.7K) of this market's total imports.
• PIPHLPT — $212.7K (20.9% of Thailand's total)
• TMBTHANACHART BANKPUBLIC CO LTD — $115.0K (11.3% of Thailand's total)
• TMBTHANACHART BANK — $115.0K (11.3% of Thailand's total)
Key Insight: Thailand's per-shipment average of $56.6K (1106% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Thailand is a key market for Tamoxifen imports from India.
People Also Ask — Tamoxifen Supplier & Trade Network
Who are the top suppliers of Tamoxifen from India?+
Which companies buy Tamoxifen from Indian manufacturers?+
Where does Tamoxifen exported from India go?+
What is the market share of the top Tamoxifen supplier from India?+
What is the average shipment value for Tamoxifen exports from India?+
Is Tamoxifen manufactured in India and exported globally?+
Which country imports the most Tamoxifen from India?+
Who are the buyers of Tamoxifen in Germany?+
How concentrated is the Tamoxifen supplier market in India?+
How do I find verified buyers for Tamoxifen in specific countries?+
Tamoxifen Trade Network — Key Takeaways
- 1EUGIA PHARMA SPECIALITIES LIMITED is India's dominant Tamoxifen exporter with a 31.9% market share and $4.7M in total exports — making it the single most important sourcing entity in this market.
- 2The top 220 suppliers collectively account for 71.3% of all tracked Tamoxifen exports, with a combined trade value of $14.7M.
- 3United States is the largest destination market, absorbing 42.5% of India's Tamoxifen exports ($6.3M). Germany (24.0%) and United Kingdom (11.1%) follow.
- 4With 3.1K total shipments averaging $4.7K each, the Tamoxifen export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include AUROBINDO PHARMA USA. INC, AUROBINDO PHARMA USA. INC, ALIUD PHARMA GMBH, TILLOMED LABORATORIES LIMITED — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 104 countries
Network value: $14.7M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tamoxifen — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Tamoxifen.
- 2.Flow Mapping: 220 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,139 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 104 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,139 Verified Shipments
220 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists